ALPHARETTA, Ga., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve ...

Clearside Biomedical (CLSD) announced the appointment of Tony Gibney as Chair of its Board of Directors, effective November 1, 2024. Gibney, who joined Clearside’s Board as an independent director in ...

ALPHARETTA, Ga., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve ...

ALPHARETTA, Ga., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical (CLSD), Inc. , a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...

Clearside Biomedical, Inc., a biopharmaceutical company focused on innovating eye therapy delivery through the suprachoroidal space, announced that CEO George Lasezkay and CMO Victor Chong will ...

ALPHARETTA, Ga., April 18, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical (CLSD), Inc. , a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...

Clearside announced an option and license agreement with Regenxbio Inc (NASDAQ:RGNX), granting the latter worldwide rights to its proprietary in-office SCS Microinjector for the delivery of RGX-314 to ...

ALPHARETTA, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...

) has been revised to $64.26 / share. This is an increase of 1,400.00% from the prior estimate of $4.28 dated September 10, 2025. The price target is an average of many targets provided by analysts.

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).

The Dow Jones closed higher by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders ...